Ovarian cancer is frequently diagnosed at an advanced stage due to nonspecific early symptoms and the lack of effective screening tools, resulting in poor clinical outcomes. Herein, we report a simple, rapid, and highly stable electrochemical sensing platform designed for the parallel detection of three ovarian cancer biomarkers. A key advantage of this system is that it enables direct antibody immobilization on copper phthalocyanine-modified gold electrode (Au/CuPc) surface, completely avoiding the need for cross-linking agents or complex activation steps. Comprehensive XPS and Raman spectroscopic analyses reveal that this binding is driven by a "His-tag-like" coordination interaction between the central Cu(II) ion of the CuPc and the imine nitrogen atoms of the antibody's histidine residues. Leveraging this robust mechanism, anti-p53, anti-STIP1, and anti-CA125 were successfully immobilized, facilitating the subsequent detection of their respective antigens via cyclic voltammetry (CV) and differential pulse voltammetry (DPV). The platform exhibited excellent analytical performance, achieving broad linear detection ranges and high sensitivities: 100.0 fg/mL to 1 ng/mL and 22.9 μA/log(pg/mL)·cm² for p53; 12.1 pg/mL to 1.21 μg/mL and 24.09 μA/log(pg/mL)·cm² for STIP1; and 4.4 to 200.0 U/mL and 56.7 μA/log(U/mL)·cm² for CA125. Because the detection ranges for all three target antigens fully encompass established clinical cut-off levels, this electrochemical platform demonstrates strong translational potential as a practical and reliable tool for ovarian cancer detection.